Table 3 Modification in lipid profile of dyslipidemic patients after simvastatin treatment by gender
Male (n = 7) | Female (n = 8) | |||
|---|---|---|---|---|
Baseline | After treatment | Baseline | After treatment | |
Total cholesterol (mg/dl) | 260 (236–316) | 208 (172–263) | 299 (278–347) | 199 (176–229)* |
LDL-cholesterol (mg/dl) | 186 (172–207) | 120 (99–160)+ | 207 (187–244) | 118 (142–203)* |
HDL-cholesterol (mg/dl) | 50 (47–57) | 54 (48–70) | 51 (47–60) | 52 (49–63) |
Tryglicerides (mg/dl) | 115 (87–134) | 114 (83–167) | 180 (142–203) | 149 (95–153) |
Apolipoprotein A (mg/dl) | 141 (136–152) | 136 (127–166) | 145 (134–163) | 147 (136–177) |
Apolipoprotein B (mg/dl) | 151 (139–168) | 90 (85–126)+ | 180 (136–269) | 101 (91–119)* |